Show simple record

dc.contributor.authorWhalley, Gillian
dc.contributor.authorEllis, Katrina L.
dc.contributor.authorFrampton, Chris M.
dc.contributor.authorPilbrow, Anna P.
dc.contributor.authorTroughton, R.W.
dc.contributor.authorDoughty, Robert N.
dc.contributor.authorEllis, Chris J.
dc.contributor.authorSkelton, Lorraine
dc.contributor.authorThomson, Judith
dc.contributor.authorYandle, Tim G.
dc.contributor.authorRichards, A.M.
dc.contributor.authorCameron, Vicky A.
dc.date.accessioned2013-05-16T01:25:52Z
dc.date.available2013-05-16T01:25:52Z
dc.date.issued2011
dc.identifier.urihttps://hdl.handle.net/10652/2124
dc.description.abstractCoronary artery disease (CAD) has multifactorial origins, and although some families are particularly affected, no precise mode of inheritance has been identified. It is likely that this reflects the contribution of numerous genetic components, each conferring a small risk in cumulative interaction with environmental factors to substantively increase disease susceptibility.1 In recent years, significant advances have been made in elucidating the genetic basis of CAD with the completion of several large genome-wide association studies (GWAS) that have looked at the DNA variation across the entire human genome. In a landmark study in 2007, the Wellcome Trust Case Control Consortium identified a region on chromosome 9 (9p21.3) that was the most strongly associated with the risk of developing CAD,2 a finding that has since been replicated in several independent studies.3–6 The 9p21.3 rs1333049 variant is common and may potentially be added to risk profiling in the future. Already it has been reported that adding the 9p21.3 genotype to the traditional risk score significantly improves CAD risk prediction in the community.7en_NZ
dc.language.isoenen_NZ
dc.relation.urihttp://circgenetics.ahajournals.org/content/4/6/636.fullen_NZ
dc.subjectcoronary disease genetic polymorphisms genome wide association studies cardiovascular diseases outcomesen_NZ
dc.titleGenomic Risk Variants at 1p13.3, 1q41, and 3q22.3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Genomic Risk Variants at 1p13.3, 1q41, and 3q22.3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Diseaseen_NZ
dc.typeJournal Articleen_NZ
dc.rights.holderCopyright © 2011 American Heart Associationen_NZ
dc.identifier.doi10.1161/CIRCGENETICS.111.960336en_NZ
dc.subject.marsden110201 Cardiology (incl. Cardiovascular Diseases)en_NZ
dc.identifier.bibliographicCitationEllis, K. L., Frampton, C. M., Pilbrow, A. P., Troughton, R. W., Doughty, R. N., Whalley, G. A., ... & Cameron, V. A. (2011). Genomic Risk Variants at 1p13. 3, 1q41, and 3q22. 3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery DiseaseClinical Perspective. Circulation: Cardiovascular Genetics, 4(6), 636-646.en_NZ
unitec.institutionUnitec Institute of Technologyen_NZ
unitec.peerreviewedyesen_NZ
unitec.identifier.roms52447
unitec.institution.studyareaHealth Sciences


Files in this item

Thumbnail

This item appears in

Show simple record


© Unitec Institute of Technology, Private Bag 92025, Victoria Street West, Auckland 1142